Cefixime Should NOT Be Given to Neonates
Cefixime is contraindicated in neonates under 6 months of age due to lack of established safety and efficacy data, and it is not recommended in any major neonatal sepsis guidelines. 1
FDA Labeling Explicitly Excludes Neonates
The FDA drug label for cefixime clearly states: "Safety and effectiveness of cefixime in children aged less than six months old have not been established." 1 This is a critical regulatory limitation that should guide clinical practice. The approved indications for cefixime include urinary tract infections, otitis media, pharyngitis, bronchitis, and gonorrhea—but notably exclude neonatal sepsis 1.
Guidelines Universally Recommend Alternative Cephalosporins
When reviewing comprehensive WHO and international guidelines for neonatal sepsis treatment, cefixime is conspicuously absent from all recommendations 2. Instead, guidelines consistently recommend:
For Early-Onset Neonatal Sepsis (first 72 hours):
- First-line: Benzylpenicillin or ampicillin PLUS gentamicin 2
For Late-Onset Neonatal Sepsis (>72 hours):
- For Gram-negative coverage: Cefotaxime or ceftriaxone (with ampicillin in neonates up to 3 months) 2
- NOT cefixime
Why Cefotaxime, Not Cefixime?
The American Academy of Pediatrics specifically states that "third-generation cephalosporins (e.g., cefotaxime) represent a reasonable alternative to an aminoglycoside" for neonatal sepsis 2. Multiple guidelines (BMJ Best Practice, NICE, BNF for Children) all recommend cefotaxime when third-generation cephalosporin coverage is needed for Gram-negative bacteria in neonates 2.
Clinical Reasoning
The distinction matters because:
- Pharmacokinetic data in neonates is lacking for cefixime—we simply don't know how it behaves in this vulnerable population
- Oral bioavailability issues: Cefixime is only 40-50% absorbed orally 1, which is problematic in critically ill neonates who need reliable drug levels
- Ceftriaxone concerns in neonates: While ceftriaxone can cause hyperbilirubinemia and kernicterus risk in neonates (especially <14 days old) 3, cefotaxime remains the safer third-generation cephalosporin option when needed
Common Pitfall to Avoid
Do not substitute cefixime for cefotaxime simply because of drug shortages or formulary limitations. If cefotaxime is unavailable, the appropriate alternatives are:
- Continue with ampicillin/benzylpenicillin + gentamicin
- Consider cefepime (with appropriate monitoring)
- Use ceftriaxone cautiously in neonates >14 days old with normal bilirubin 3
Bottom Line
Use the evidence-based regimens: ampicillin or benzylpenicillin PLUS gentamicin for first-line neonatal sepsis treatment. Reserve cefotaxime (not cefixime) for documented Gram-negative infections or when aminoglycosides are contraindicated. 2